2022

1. First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: a retrospective observational study (RETOSS-ENDO)

   Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 540-542